Chemically modified heparin derivatives offer a potential source of effective inhibitors of viral attachment, which are suitable for further optimisation.
No takes yet. Share an insight, caveat, or question.
Skidmore et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: